GSK plc (LSE:GSK) Annual Report 2022

The latest annual report of GSK plc (GSK) was published on 31 Dec 2022. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - GSK Annual Results

Amounts in GBP

Total Revenue
Gross Profit
Net Tangible Assets
Net Income
Capital Expenditures

GSK Income Statement 2022 Annual Report

As per the latest Income Statement of GSK, the Net revenue increased by £4.628B (19%) compared to the previous period. The operating income in 2022 increased by £1.688B (30%). The net income as per the annual report was 14.96B which increased by £10.571B (241%) compared to previous year.

Income Statement Report (2022/2021)

2022 2021
Total Revenue 29.32B 24.7B
Gross Profit 19.92B 16.66B
Operating Income 7.32B 5.63B
Income Before Tax 5.63B 3.6B
Net Income 14.96B 4.38B

Balance Sheet - GSK 2022 Annual Report

Read further: GSK Balance Sheet Detailed Analysis

The latest balance sheet from annual result of GSK plc showed the company reduced the cash on balance sheet by £-551.00M (-13%). The Net tangible assets of GSK on the balance sheet were at -10.77B which is £14.81B (58%) more than previous annual report. The total stockholder equity also decreased by £-4.457B (-30%) compared to previous reporting period.

Balance Sheet Statement Report (2022/2021)

2022 2021
Cash 3.72B 4.27B
Total Assets 60.15B 79.1B
Long Term Debt 16.19B 19.76B
Total Liabilities 50.05B 57.76B
Total Shareholder Equity 10.6B 15.05B
Net Tangible Assets -10.77B -25.58B

Cash Flow Statement - GSK 2022 Annual Report

The 2022 annual cash flow statement of GSK plc showed that the net income increased by £10.571B (241%) compared to previous reporting period. Also the capital expenditure of GSK decreased by £-193.00M (-20%).

As of 2022, the total cash from investing activities was -8.77B and total cash from financing activities was 823M.

Cash Flow Statement Report (2022/2021)

2022 2021
Net Income 14.96B 4.38B
Capital Expenditures -1.14B -950M
Dividends Paid -3.47B -4B
Total Cash From From Investing Activities -8.77B -1.78B
Total Cash From From Financing Activities 823M -7.59B

GSK plc Annual Report History

Income Statement

Income Statement history of GSK plc (LSE:GSK)

31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Total Revenue 29.32B 24.7B 24.35B 33.75B
Cost Of Revenue 9.41B 8.03B 7.32B 10.79B
Gross Profit 19.92B 16.66B 17.03B 22.96B
Research Development 5.15B 4.63B 4.4B 4.41B
Selling General Administrative 8.18B 6.78B 7.04B 10.96B
Non Recurring - - - -
Other Operating Expenses -737M -382M -455M -606M
Total Operating Expenses 22B 19.06B 18.3B 25.55B
Operating Income 7.32B 5.63B 6.05B 8.2B
Total Other Income Expense Net -1.69B -2.04B -880M -1.98B
Ebit 7.32B 5.63B 6.05B 8.2B
Interest Expense -819M -762M -844M -877M
Income Before Tax 5.63B 3.6B 5.17B 6.22B
Income Tax Expense 707M 83M 67M 953M
Minority Interest -502M 6.29B 6.22B 6.95B
Net Income From Continuing Ops 4.92B 3.52B 5.1B 5.27B
Discontinued Operations 10.49B 1.07B 876M 876M
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income 14.96B 4.38B 5.75B 4.64B
Net Income Applicable To Common Shares 14.96B 4.38B 5.75B 4.64B

Balance Sheet Statement

Balance Sheet Statement history of GSK plc (LSE:GSK)

31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Cash 3.72B 4.27B 6.29B 4.71B
Short Term Investments 750M 614M 480M 786M
Net Receivables 6.43B 7.48B 6.86B 6.44B
Inventory 5.15B 5.78B 6B 5.95B
Other Current Assets 123M 133M 195M 941M
Total Current Assets 20.77B 18.67B 20.25B 19.49B
Long Term Investments 1.57B 2.28B 3.5B 2.28B
Property Plant Equipment 9.62B 10.67B 11.01B 11.31B
Good Will 7.05B 10.55B 10.6B 10.56B
Intangible Assets 14.32B 30.08B 29.82B 30.95B
Other Assets 6.82B 6.85B 5.26B 5.09B
Deferred Long Term Asset Charges 5.66B 5.22B 4.29B 4.1B
Total Assets 60.15B 79.1B 80.43B 79.69B
Accounts Payable 3.87B 4.54B 4.36B 4.14B
Short Long Term Debt 2.3B 2.69B 2.45B 1.71B
Other Current Liab 10.96B 10.67B 5.4B 4.78B
Long Term Debt 16.19B 19.76B 22.54B 22.58B
Other Liab 10.21B 13.52B 14.05B 13.7B
Minority Interest -502M 6.29B 6.22B 6.95B
Total Current Liabilities 22.81B 23.67B 22.15B 24.05B
Total Liab 50.05B 57.76B 59.62B 61.34B
Common Stock 1.35B 1.35B 1.35B 1.35B
Retained Earnings 4.79B 8.75B 7.29B 5.05B
Treasury Stock 1.02B 1.66B 2.67B 1.83B
Capital Surplus 3.44B 3.3B 3.28B 3.17B
Other Stockholder Equity 1.02B 1.66B 2.67B 1.83B
Total Stockholder Equity 10.6B 15.05B 14.59B 11.4B
Net Tangible Assets -10.77B -25.58B -25.83B -30.11B

Cash Flow Statement

Cash Flow Statement history of GSK plc (LSE:GSK)

31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net Income 14.96B 4.38B 5.75B 4.64B
Depreciation 2.15B 2.12B 2.05B 2.33B
Change To Netincome -8.34B 1.12B -275M 769M
Change To Account Receivables -158M -780M -279M -32M
Change To Liabilities 494M 229M 132M 263M
Change To Inventory -269M 51M 100M 300M
Change To Operating Activities -1.43B 824M 964M -259M
Total Cash From Operating Activities 7.4B 7.95B 8.44B 8.02B
Capital Expenditures -1.14B -950M -989M -1.26B
Investments 95M 334M 2.85B -199M
Other Cashflows From Investing Activities -3.72B -99M 864M 89M
Total Cashflows From Investing Activities -8.77B -1.78B 2.16B -5.35B
Dividends Paid -3.47B -4B -3.98B -3.95B
Net Borrowings -4.82B -2.18B -4.22B 3.52B
Other Cashflows From Financing Activities 9.09B -1.43B -1.97B -1.45B
Total Cash From Financing Activities 823M -7.59B -10.13B -1.84B
Effect Of Exchange Rate 152M -29M -39M -82M
Change In Cash -394M -1.44B 431M 744M
Issuance Of Stock 25M 21M 29M 51M